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Abstract
© 2016, Springer Science+Business Media New York.Familial hemiplegic migraine (FHM) is a
rare monogenetic form of migraine associated with aura and motor dysfunctions. Molecular
mechanisms of FHM still remain unknown; however, genetic predisposition to the disease has
been suggested. We report several cases of FHM diagnosed in three generations of ethnic
Tatars, Russian Federation. Apart from clear family character, patients presented with typical
features of FHM including aura and ataxia. In order to determine disease genetic markers in
these cases, we sequenced several genes (CACNA1A, ATP1A2, and SCN1A) previously reported
in FHM. Sequence analysis demonstrated absence of the previously identified mutations in
genes studied. This is the first genetic study of FHM in the Tatar population. The lack of known
FHM associated mutation in these patients suggests presence of yet unidentified mutations in
some other genes. Further studies including full genome sequencing are needed to clarify the
genetic background of FHM cases in the Tatar population.
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